|
Finally, a
scientific breakthrough that offers significant protection against cervical
cancer and genital warts. Worldwide, over 500,000 cases of cervical cancer are
diagnosed in women each year. Now, the Human Papilloma Virus (HPV) vaccine can
offer women 70% protection against the development of cervical cancer and
genital warts over a lifetime (see photo inset of patient with severe case of
genital warts.) The HPV vaccine protects against serotypes 6, 11, 16 and 18 of
the Human Papilloma Virus. The Human Papilloma Virus is sexually transmitted and
is the known causative agent of genital warts and cervical cancer in women. The
HPV vaccine offers optimal protection if received between the ages of 9 to 26
years of age. However, women beyond the age of 26 may benefit from the vaccine
if they have never been exposed to the Human Papilloma Virus serotypes 16, 18, 6
and 11. The Gardisil HPV vaccine is a three injection series given over a six
month period. The major side effect, noted in less than 5% of vaccine
recipients, is redness at the injection site. However, the HPV vaccine is not a
substitute for routine gynecological evaluations and pap smears. But widespread
use of the HPV vaccine offers hope for a dramatic decline in deaths due to
cervical cancer over time.
If you would like to receive the HPV vaccine call 718-624-0604 to schedule an
appointment. |
Severe case of Condyloma Accuminata
or genital warts
Graphic courtesy of
Prof. Erwin J. Haeberle
|
